Fagron N.V. (FAGR) is a Drug manufacturers specialty generic company in the Healthcare sector, listed on Euronext Brussel. This page provides the complete earnings calendar, dividend schedule, and financial data for Fagron N.V. in 2026. The next earnings report is expected on February 18, 2027.
Next earnings date
18 Feb 2027
In 181 days
EPS estimate
—
Revenue estimate
619.6M
Past earnings
Latest earnings analysis
Fagron N.V. beat consensus estimates on revenue in its latest earnings report, with revenue of USD 630.99 million exceeding estimates by 1.8%, while EPS was not disclosed. In the prior quarter revenue totaled USD 560.84 million and there were no consensus comparisons provided for EPS or revenue.
Next ex-dividend
—
Not scheduled
Next payment
—
Not scheduled
Dividend amount
—
Not available
Past dividends
| Ex-dividend | Payment | Amount |
|---|---|---|
| 18 May 2026 | 20 May 2026 | 0.33 |
Fagron NV, a pharmaceutical compounding company, provides personalized medicine care to hospitals, pharmacies, clinics, and patients. The company also innovates concepts, vehicles, and formulations for pharmaceutical compounding. In addition, it supplies raw materials, utensils and equipment, semi-finished products, vehicles, and sterile and non-sterile compounded medicines. Further, the company offers education and training program to prescribers and pharmacists through the Fagron Academy. It has operations in Latin America, North America, Europe, the Middle East, and Africa. The company was formerly known as Arseus NV and changed its name to Fagron NV in January 2015. Fagron NV was founded in 1990 and is based in Nazareth, Belgium.
Fagron N.V. (FAGR) is scheduled to report earnings on February 18, 2027.
Fagron N.V. (FAGR) last reported earnings on July 30, 2026.
Fagron N.V. (FAGR) is listed on Euronext Brussel.
We use cookies to make our website work and improve your experience. With your consent, we also use cookies for analytics and advertising.